Last night I had the same idea as Ingeborg (see her "Reference comments") and asked for more info.
The following is a personal message I received from John last night and found this morning, which confirms that Ingeborg is right:
"Hi Marga, I don't know how to post this on the KudoZ site, but here it is:
'A phase 2 randomized, controlled, open-label
(dose-blinded), multi-center, dose-finding study of the
safety and efficacy of I-0401 in the treatment of patients
with fractures of the tibial plateau requiring grafting.' "
Ingeborg, please enter your "Reference comment" as an answer. It has to be the correct answer.
http://docs.google.com/gview?a=v&q=cache:naWYh4kuw6wJ:www.ba...
(The English version is the last column)
(In a reply to his message I also tried to explain to John how to make a "Discussion entry").